Merck & Co., Inc. Executive Compensation
Named executive officer pay as disclosed in the company’s d85708ddef14a.htm proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.
$20,797,845
Robert M. Davis, Chief Executive Officer — total compensation
$1,645,302
base salary
Healthcare
industry
| Executive | Title | Base salary | Total compensation |
|---|---|---|---|
| Robert M. Davis | Chairman, Chief Executive Officer and President | $1,645,302 | $20,797,845 |
| Dean Li, M.D., Ph.D. | Executive Vice President and President, Merck Research Laboratories | $1,460,000 | $8,892,881 |
| Caroline Litchfield | Executive Vice President and Chief Financial Officer | $1,173,214 | $7,514,085 |
| Jennifer Zachary | Executive Vice President and General Counsel | $1,062,217 | $5,860,578 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | $982,170 | $5,408,408 |
Source: Merck & Co., Inc. Definitive Proxy Statement (DEF 14A), filed d85708ddef14a.htm with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.
Other Healthcare companies
UNITEDHEALTH GROUP INC
Healthcare
$60,938,062
Stephen Hemsley, CEO
ELI LILLY & Co
Healthcare
$36,698,337
David A. Ricks, CEO
JOHNSON & JOHNSON
Healthcare
$32,758,111
J. Duato, CEO
AbbVie Inc.
Healthcare
$32,530,984
Robert A. Michael, CEO
GILEAD SCIENCES, INC.
Healthcare
$28,437,198
Daniel P, CEO
PFIZER INC
Healthcare
$27,585,301
A. Bourla, CEO
